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AbsTrACT
Introduction Gunshot wounds to the brain (GSWB) 
confer high lethality and uncertain recovery. It is unclear 
which patients benefit from aggressive resuscitation, and 
furthermore whether patients with GSWB undergoing 
cardiopulmonary resuscitation (CPR) have potential 
for survival or organ donation. Therefore, we sought to 
determine the rates of survival and organ donation, as 
well as identify factors associated with both outcomes in 
patients with GSWB undergoing CPR.
Methods We performed a retrospective, multicenter 
study at 25 US trauma centers including dates between 
June 1, 2011 and December 31, 2017. Patients were 
included if they suffered isolated GSWB and required 
CPR at a referring hospital, in the field, or in the trauma 
resuscitation room. Patients were excluded for significant 
torso or extremity injuries, or if pregnant. Binomial 
regression models were used to determine predictors of 
survival/organ donation.
results 825 patients met study criteria; the majority 
were male (87.6%) with a mean age of 36.5 years. 
Most (67%) underwent CPR in the field and 2.1% 
(n=17) survived to discharge. Of the non- survivors, 
17.5% (n=141) were considered eligible donors, with a 
donation rate of 58.9% (n=83) in this group. Regression 
models found several predictors of survival. Hormone 
replacement was predictive of both survival and organ 
donation.
Conclusion We found that GSWB requiring CPR 
during trauma resuscitation was associated with a 2.1% 
survival rate and overall organ donation rate of 10.3%. 
Several factors appear to be favorably associated with 
survival, although predictions are uncertain due to the 
low number of survivors in this patient population. 
Hormone replacement was predictive of both survival 
and organ donation. These results are a starting point for 
determining appropriate treatment algorithms for this 
devastating clinical condition.
Level of evidence Level II.
bACkground
In the USA, there are approximately 70 000 victims 
of gunshot wounds resulting in an estimated 30 000 
deaths per year.1 Gunshot wounds to the brain 
(GSWB) are a subset of these injuries that carry 
high lethality and uncertain recovery; however, 
aggressive resuscitation has been associated with 
increased survival and organ donation.2 During 
the last several years, GSWB have gained national 
and international interest after US Congresswoman 
Gabrielle Gifford sustained a gunshot wound to 
her brain in an attempted assassination in 2011. 
She received aggressive management and ultimately 
recovered well. Cases such as hers reinforce the 
need for evidence- based algorithms for the manage-
ment of these injuries.3
Multiple studies have analyzed different predic-
tive factors for prognosis of patients with GSWB. 
Until recently, patients with a Glasgow Coma Scale 
(GCS) score of 3–5 or bihemispheric head injuries 
did not always receive aggressive resuscitation due 
to the high mortality rate of the injury.4–6 More 
recently, though, Joseph and colleagues conducted a 
retrospective analysis which showed that aggressive 
resuscitation—specifically hemostatic resuscitation 
with blood components and hyperosmolar ther-
apy—was associated with increased survival and 
organ donation regardless of GCS at presentation.2
Determining which patients would benefit from 
aggressive resuscitation is necessary to refine 
management and improve resource utilization. An 
immediate question is whether patients with GSWB 
2 Robinson LA, et al. Trauma Surg Acute Care Open 2019;4:e000351. doi:10.1136/tsaco-2019-000351
Open access
Table 1 Patients contributed by participating institutions
Trauma center Eligible patients
University of Maryland 100
University Medical Center Las Vegas 76
University of Alabama 72
Johns Hopkins University 60
Tulane Medical Center 60
Harborview Medical Center 52
University of California- Irvine 50
St Mary’s Medical Center 35
MetroHealth 35
Cooper Health 32
University of Illinois- Chicago 32
Allegheny Health 26
Mount Sinai Hospital- Chicago 24
Jackson Memorial Hospital- Miami 22
University of Mississippi 19
Grant Medical Center 18
Christiana Healthcare System 17
Memorial Regional Hospital 16
Broward Health 14
University of Kansas 14
University of Pennsylvania 13
Loma Linda University 11
Mass General Hospital 10
University of California- San Diego 10
Spartanburg Medical Center 7
undergoing cardiopulmonary resuscitation (CPR) during trauma 
resuscitation either recover or become donors, as this has not 
been specifically addressed in prior investigations on this topic. 
To inform future work in this area, we sought to determine the 
rates of survival and organ donation, as well as identify factors 
associated with both outcomes in patients with GSWB under-
going CPR.
METhods
study population
We identified patients through a retrospective, multicenter 
study at 25 US level I and level II trauma centers between June 
1, 2011 and December 31, 2017. Patients who suffered GSWB 
and required CPR at the referring hospital, in the field, or at 
the trauma center were included. Exclusion criteria were signif-
icant torso or extremity injuries (Abbreviated Injury Scale (AIS) 
score greater than 2 for thorax, abdomen, spine, upper or lower 
extremities, or unspecified) or current pregnancy. Data were 
collected for a total of 825 patients meeting these criteria. All 
data were collected from the participating level I and level II 
trauma centers. Data from referring facilities and prehospital 
were not collected.
outcomes
The primary outcome was survival rate, defined as the number 
of patients surviving hospitalization among the total number of 
patients meeting study criteria. Secondary outcomes included 
rate of successful donation of any organ, predictors of organ 
donation, predictors of survival, overall cost of treatment, cost 
of survival, and cost of organ donation.
statistical analysis
Depending on distribution of the data, continuous variables 
are presented as mean±SD or median with IQR. Categorical 
variables are presented as frequencies and percent. A binomial 
logistic regression was considered to determine predictors of 
survival. Due to the very low frequency of survival (17 survivors 
vs. 808 non- survivors), a multiple logistic regression model was 
not possible. Thus, an exploratory complete case analysis was 
undertaken to examine bivariate relationships between survival 
and several predictors. Predictors were selected on the basis of 
significant correlation with survival using χ2 contingency tables 
(for categorical predictors) or Kruskal- Wallis one- way analysis 
of variance test (for continuous predictors). Each predictor 
was individually fitted to a binomial regression model using 
maximum likelihood estimators.
For the subset of 808 non- survivors, binomial logistic regres-
sion was again considered to determine predictors of organ 
donation. Model selection was performed with the ‘regsubset’ 
function in R using an exhaustive search approach. Using selec-
tion criteria (adjusted R2, Mallow’s Cp, and Bayesian infor-
mation criterion), a three- predictor model was fitted for 627 
subjects with complete data. Results are reported in terms of 
ORs. Statistical significance for all analyses was predetermined 
at p≤0.05, which is reported alongside 95% CIs. All analyses 
were conducted with R V.3.5.1 (2018-07-02).
rEsuLTs
A total of 825 patients from 25 trauma centers with isolated 
GSWB met study criteria (table 1). The majority were male 
(87.6%) with a mean age of 36.5 years. Most (67%) underwent 
CPR in the field. There was no significant difference in mortality 
by location of CPR (98.7% in the field vs. 98.2% in- hospital). 
Only 2.1% (n=17) survived to discharge; 47% went to reha-
bilitation, 27% home, 20% skilled nursing facilities, and 13% 
long- term acute care. Of the patients who did not survive, 
17.5% (n=141) were considered eligible donors by the local 
organ procurement organization, with a donation rate of 58.9% 
(n=83) in this group and an overall donation rate of 10.3% 
among non- survivors. Survivors had lower Injury Severity 
Score (ISS) (international normalized ratio (INR) 22.2 vs. 37.4, 
p=0.003) (table 2). Data on resuscitative interventions, neuro-
surgical interventions, and base deficit were collected; however, 
due to a large amount of missing data, these measures were not 
found to significantly impact results.
Several individual binomial regression models identified 
factors associated with survival (table 3). Fifty- five patients 
required transfer to a level I or level II trauma center but did 
not have significantly different characteristics in terms of age, 
ISS, and AIS head. However, transfer patients were more likely 
to survive (p=0.0001). Non- surviving transfer patients were 
more likely to become organ donors than those who were not 
transferred (25% vs. 9.8%). Survivors also received more units 
of packed red blood cells (RBC; mean 4.8 units vs. 1.6 units, 
p=0.0007), plasma (2.3 units vs. 0.8 units, p=0.009), platelets 
(0.87 units vs. 0.16 units, p=0.01), and larger volumes of crys-
talloid (6.7 L vs. 2.4 L, p=0.002).
Overall, the frequency of organ donation was low (83 donors 
vs. 693 non- donors). The mean age for donors was significantly 
less than non- donors (32.5 years vs. 37.1 years, p=0.007). As 
expected, donors presented with higher systolic blood pres-
sure (86.7 mm Hg vs. 41.8 mm Hg, p<0.001) and heart rate 
(85.7 bpm vs. 42.9 bpm, p<0.001). Donors also received 
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Table 2 Patient demographics
Total survivors non- survivors
Age 31 (23–46) 32 (23–44) 31 (23–46)
Male gender 723 (88) 14/17 (82) 709/808 (88)
Race
  Black 362 (44) 9 (56) 353 (47)
  White 340 (41) 5 (31) 335 (45)
  Other 123 (15) 2 (13) 57 (8)
Injury Severity Score 26 (25–41) 25 (17–26) 26 (25–75)
Abbreviated Injury Scale- Head 5 (5–6) 5 (4–5) 5 (5–6)
Injury intent
  Assault 355 (50) 11 (65) 344 (50)
  Suicide 294 (41) 6 (35) 288 (42)
  Accident 54 (8) 0 54 (8)
  Legal intervention 6 (1) 0 6 (1)
Table 3 Predictors of survival to hospital discharge
Predictor sample size or 95% CI P value
Signs of life at trauma center 824 8.30 2.32 to 52.91 0.001
Receipt of tranexamic acid (TXA) 793 7.90 1.71 to 27.15 0.0001
Transfer to level I/II trauma center 793 6.61 2.02 to 18.94 0.000
Replacement of ≥1 hormone(s) 819 3.82 1.32 to 10.79 0.01
Units of platelets 801 1.66 1.16 to 2.21 0.001
Units of packed red blood cells 803 1.14 1.05 to 1.22 0.000
Systolic blood pressure 745 1.02 1.01 to 1.03 0.000
Injury Severity Score 769 0.55 0.23 to 0.76 0.01
Abbreviated Injury Scale 609 0.48 0.28 to 0.87 0.01
Table 4 Predictors of successful organ donation
Predictor sample size or 95% CI P value
Volume (L) of crystalloid 453 1.15 1.06 to 1.26 0.001
Replacement of ≥1 hormone(s) 453 10.03 5.19 to 20.13 0.000
significantly more units of packed RBCs (4.2 units vs. 1.3 units, 
p<0.0001), platelets (0.63 units vs. 0.11 units, p<0.0001), and 
larger volumes of crystalloid (4.9 L vs. 2.2 L, p<0.0001). ISS 
and AIS head were not statistically different between donors and 
non- donors. Independent predictors of organ donation were 
crystalloid volume and replacement of one or more hormones 
(methylprednisolone, vasopressin, insulin, or levothyroxine/
triiodothyronine) (table 4).
Specifically, each additional 1 L of crystalloid resulted in 
15.4% increased odds of organ donation (95% CI 5.98 to 26.5, 
p=0). However, it is important to note that this association is 
likely, in part, due to fluid imbalance secondary to brain death 
and subsequent homeostatic derangements. Replacement of at 
least one hormone was associated with over 10- fold increased 
odds of organ donation (OR 10.03, 95% CI 5.19 to 20.13, p=0).
Due to positively skewed data, costs (in US$) are reported 
in geometric averages to mitigate the effect of exceptionally 
large values.7 The total cost for all patients with reported data 
(n=488) was $22.7 million dollars. The geometric average cost 
of treatment per patient was $24 176. Cost of survival was 
reported for 8 of the 17 survivors and totaled $1.7 million. The 
geometric average cost of treatment per survivor was $188 480. 
In contrast, treatment of non- survivors totaled $21 million with 
a geometric average of $23 363 per non- survivor (for n=480 
non- survivors). Cost of organ donation was $5.6 million overall 
with a geometric average of $56 870 per organ donor (for n=56 
donors). The organ procurement organization—not the trauma 
center—assumes all costs related to donation.
dIsCussIon
GSWB have high rates of mortality and morbidity. Our current 
understanding of these lethal injuries is primarily extrapolated 
from lessons learnt through military experiences, which tend 
to report improved outcomes with more aggressive manage-
ment.8 Prospective civilian studies are sparse and often contain 
lower levels of evidence. Thus, there is no standard approach 
to treating these injuries in the published literature. In effort to 
address this deficit, our current effort was to identify specific 
factors associated with patient outcome—namely survival or 
organ donation. In this study, we report several resuscitative 
practices that are associated with survival to hospital discharge 
or organ donation in patients with GSWB who subsequently 
underwent CPR (tables 3 and 4).
An interesting parallel between our study and others with 
similar patient populations is the effect—or lack thereof—of age, 
race, and intent on outcome. Our study population had large 
disparities between these groups; assault was more common 
among black patients (235 black vs. 64 white) whereas suicides 
were more frequent in white patients (212 white vs. 42 black). 
Additionally, black patients in our study were significantly 
younger (mean 29.8 years vs. 45.0 years in white patients). 
Despite these differences, neither age, race, nor intent was 
predictive of survival. Similarly, Crutcher et al9 reported dispar-
ities in injury intent between races, but intent and race were not 
predictive of survival in this study either.
With regard to specific factors associated with survival, various 
items have been previously identified. In a 2016 study, Jesin et 
al10 concluded that mortality was related to increasing ISS and 
age. Lee et al11 found GCS, AIS head, and age to be associated 
with survival in isolated head trauma but did not focus on pene-
trating injuries. In contrast, the strongest factors associated with 
outcome in our study were signs of life (SOL) on arrival, receipt 
of tranexamic acid (TXA), and transfer to a higher level trauma 
center. Patients who arrived at a trauma center with SOL were 
8.3 times more likely to survive. We could not find any other 
published literature that documented SOL as a statistically signif-
icant predictor of outcome for this specific injury.
We found that receipt of TXA had a significant effect on 
survival (OR 7.90, p=0.0001). A meta- analysis12 of the two 
largest randomized controlled trials13 14 on TXA in traumatic 
brain injury (TBI) found a significant reduction in intracranial 
hemorrhage expansion (relative risk (RR)=0.72) and mortality 
(RR=0.63) when TXA had been given. Yet unpublished, the 
results of the Clinical Randomization of an Antifibrinolytic in 
Significant Head Injury-3 trial, an international multicenter 
randomized trial studying the effects of TXA in TBI, are expected 
to provide novel and clinically significant information. Our third 
strongest predictor of survival, transfer to a trauma center, has 
been associated with lower risk of death in prior studies.15 16 In 
this study, patients transferred to trauma centers were 6.6 times 
more likely to survive. Similarly, Sugerman et al17 reported an 
improved survival rate when patients with severe TBI were 
transferred to a trauma center.
As discussed above, a wide range of survival- associated factors 
have been identified—both in our study and previous reports. 
Without significant overlap of results, the interpretation of 
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data and application of specific management is challenging. 
Muehlschlegel et al18 have attempted to combine several predic-
tors into the Surviving Penetrating Injury to the Brain (SPIN) 
score, a logistic regression- based clinical risk stratification scale 
estimating survival after penetrating TBI. Components of the 
SPIN score include motor GCS, pupillary examination, whether 
the injury was self- inflicted, transfer status, gender, ISS, and INR. 
Although the SPIN score does not address CPR, it does include 
transfer and ISS, which were both significant predictors in our 
study. Further identification of similar threads across studies may 
reveal that certain predictors are more consistent and significant 
than others.
A particularly noteworthy area is hormone replacement 
therapy. In our study, patients who received at least one hormone 
(methylprednisolone, insulin, vasopressin, and/or thyroid 
hormone) during the initial resuscitation had significantly 
improved survival or greater rates of successful organ donation. 
However, the overall donation rate was very low at 10.3% of 
non- survivors. This is lower than other reported rates in the 
literature, which range from 26.1% to 34.7% in patients with 
GSWB.19 20 This is likely because our study focused on patients 
in extremis at the time of presentation, and thus, the least likely 
to be salvageable. The findings of this study and numerous other 
retrospective reports2 21–24 on the benefits of hormone replace-
ment therapy have provided the basis for a future prospective, 
randomized trial.
LIMITATIons
The primary limitation of our study is its retrospective design 
and reliance on a registry for data collection. This registry is 
subject to errors, incompleteness, and interhospital differences 
in reporting practices. This multi- institutional study included 
several level 1 trauma centers that tend to see a dispropor-
tionate number of high- acuity injuries. As such, the patient 
sample is not necessarily representative of all US trauma 
centers.
Additionally, institutional differences and physician- specific 
biases may have contributed to different approaches to resus-
citation. A particularly important example is the differences in 
hormone replacement usage. Although we did not specify the 
timing of administration, some institutions/physicians have 
begun using hormones as part of the initial resuscitation in the 
trauma bay whereas others use these therapies only in patients 
who have either impending or declared brain death. Thus, the 
use and timing of hormone replacement is a critical area for 
future study in these patients.
Another limitation of this study—and others like it—is the 
uncertainty in making statistically significant associations. As 
evidenced above, there is a wide range of reported factors asso-
ciated with outcome that differs between studies. One reason for 
this observation is the low frequency of survival in GSWB, which 
renders the inferences drawn from these populations extremely 
uncertain. With mortality of GSWB approaching 98.0%, survival 
is considered a ‘rare event’. Statistically speaking, ‘[t]he cost 
of numerically calculating probabilities of rare events rapidly 
becomes prohibitive as the event of interest becomes rare.’25 In 
this study, the low survival rate precluded us from controlling 
for covariates when identifying factors associated with survival. 
Additionally, it is also important to note that these factors 
are subject to survival bias (eg, survivors may have received 
more fluid and blood product resuscitation because they lived 
(longer)).
ConCLusIon
Survival after GSWB involving cardiopulmonary arrest is rare; 
however, this multi- institutional study of patients with GSWB 
who received CPR identified several factors associated with 
outcome. These data represent a starting point to determine 
appropriate treatment algorithms that maximize survival and 
organ donation and minimize wastage of scarce and expensive 
resources. Our findings suggest that patients with GSWB and 
subsequent CPR should be transferred to a trauma center when 
clinically feasible. Outcomes (both survival and organ donation) 
may be favorably impacted when trauma resuscitation includes 
hormone replacement, TXA, and blood transfusions. Although 
the survival rate for this injury is dismal, 10% of patients 
became organ donors with the potential of saving numerous 
lives. Many gaps in our understanding of this complex clinical 
problem remain and further prospective studies are necessary 
to develop standard practice for the management of patients 
with GSWB.
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